ICTD 2023 - EU Recommendations on Decentralised Elements in Clinical Trials - Ditte Zerlang Andersen

Ditte Zerland Andersen explained that as they worked to develop the recommendations they were aware that they would not be able to harmonise them due to differences in national legislation. She explains how they worked to harvest the new opportunities that DCTs provide and that maintaining the clinical trial oversite remains the biggest challenge that regulators need to address.